{"id":"W4381136693","doi":"10.1016/j.annonc.2023.06.002","title":"ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Hospital Foundation; Queen's University","funders":"Genentech; Servier; European Society for Medical Oncology; Fondazione Beretta; Ipsen; BeiGene; Eisai; Jazz Pharmaceuticals; Gilead Sciences; European Federation of Pharmaceutical Industries and Associations; European Commission; Sanofi; Astellas Pharma; Celldex Therapeutics; Amgen; Pfizer; Celgene; Eli Lilly and Company; AstraZeneca; Seagen; Agios Pharmaceuticals","keywords":"Medicine; Clinical trial; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005833475,0.00107517,0.001549758,0.003761338,0.0003089563,0.002880251,0.001749359,0.001255765,0.1237678],"category_scores_gemma":[0.0593411,0.0007099779,0.002327214,0.005768048,0.0003987286,0.001986083,0.002158347,0.002175432,0.02835591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001134316,"about_ca_system_score_gemma":0.001976373,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007171027,"about_ca_topic_score_gemma":0.005501298,"domain_scores_codex":[0.9957674,0.00149672,0.0010789,0.0002289475,0.001225892,0.0002022151],"domain_scores_gemma":[0.9773736,0.01428623,0.003088869,0.001090631,0.003547362,0.0006133036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.001460785,0.0001488865,0.02521257,0.002724553,0.0006960647,0.00006150419,0.000168615,0.003445509,0.00008585277,0.008973276,0.9093548,0.04766762],"study_design_scores_gemma":[0.002882555,0.0005067511,0.160545,0.002578527,0.0006924442,0.0003791828,0.0003869209,0.007928439,0.0006317373,0.03909081,0.7841414,0.0002363204],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"methods","genre_scores_codex":[0.009915967,0.002204846,0.007055642,0.00183487,0.0004733675,0.002045011,0.9366027,0.003808731,0.0360589],"genre_scores_gemma":[0.1400865,0.003924377,0.04017414,0.001800198,0.0008236731,0.01857975,0.7560137,0.005087646,0.03350998],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.1237678,"threshold_uncertainty_score":0.4140446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2509559698425497,"score_gpt":0.4150580455189408,"score_spread":0.1641020756763911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}